Viewing data from:

TRELSTAR

NDA

TRIPTORELIN PAMOATE | N021288 | VERITY PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

BACHEM AGTRIPTORELIN PAMOATE

DMF 62911986

DEBIOPHARM RESEARCH AND MANUFACTURING SATRIPTORELIN PAMOATE MICROGRANULES

DMF 303642016

HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDTRIPTORELIN

DMF 399312024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

14 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 11.25MG BASE/VIAL

RLD

0 patents0 exclusivities▴

INJECTABLE;INTRAMUSCULAR | Approved: Jun 29, 2001

No patent or exclusivity listings for this strength.